stella
beta
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy — Stella
Recruiting
Back to Limited-stage Small Cell Lung Cancer (LS-SCLC) trials
Trial locations
(1 site)
China
Peking University Cancer Hospital & Institute, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov